Preclinical Imaging Market Research Report – Global Forecast till 2027

Preclinical Imaging Market Research Report: by Product (Optical Imaging, Nuclear Imaging, Micro-MRI, Micro-Ultrasound, Micro-CT, Photoacoustic Imaging System), by Reagent (Optical, Nuclear, CT Contrast Agents, MRI Contrast Agents) - Global Forecast Till 2027

ID: MRFR/HC/5896-HCR | February 2021 | Region: Global | 110 pages

Please note that the assessment period of report has been updated from 2018-2023 to 2020-2027. Cordially fill the sample form for updated data.

Market Scenario


Global preclinical imaging market is expected to grow significantly over the forecast period. It is anticipated that the market held value of USD 2.01 billion in 2017 and is projected to grow at a CAGR of 6.3% over the forecast period.


The factors such as technological advancements in the field of molecular imaging, increasing market demand for non-invasive small-animal imaging techniques, and increasing funding to support preclinical researches are expected to propel the growth of the market. However, strict regulations in preclinical research and high installation and operational costs associated with preclinical imaging modalities hamper the market growth over the forecast period.


Segmentation


The global preclinical imaging market has been segmented into modality, reagent, and region.


Based on modality, preclinical imaging market is segmented into optical imaging systems, nuclear imaging systems, micro-MRI, micro-ultrasound, micro-CT, photoacoustic imaging system, and magnetic particle imaging systems. The optical imaging systems segment is expected to account for the largest share segment of the market in 2017.


Based on reagent, preclinical imaging market is segmented into preclinical optical imaging reagents, preclinical nuclear imaging reagents, preclinical MRI contrast agents, preclinical ultrasound contrast agents, and preclinical CT contrast agents. The preclinical optical imaging reagents segment is expected to account for the largest share segment of the market in 2017.


The preclinical imaging market segmented, by region, into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The preclinical imaging market in the Americas further segmented into North America and South America, with the North American market divided into the US and Canada.


The European preclinical imaging market has been segmented into Western Europe and Eastern Europe. Western Europe has further been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe.


The preclinical imaging market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. The preclinical imaging market in the Middle East & Africa segmented into the Middle East and Africa.


Regional Market Summary


Global Preclinical Imaging Market Share (%), by Region, 2017


Preclinical Imaging Market


Source: Annual Reports and Sec filings


Geographically, the Americas is anticipated to dominate the global preclinical imaging market owing to a well-established player, technological advancements in the field of molecular imaging, increasing market demand for non-invasive small-animal imaging techniques, and increasing funding to support preclinical researches.


Europe is expected to hold the second largest position in the global preclinical imaging market. The market growth in this region is attributed to increasing funding to support preclinical researches.


The preclinical imaging market in Asia-Pacific region consists of countries namely China, Japan, Republic of Korea, India, Australia and Rest of Asia-Pacific. The Asia-Pacific region is expected to be fastest growing region.


The Middle East & Africa has the least share of the preclinical imaging market.


Global Preclinical Imaging Market, by Modality



  • Optical Imaging Systems

    • Bioluminescence/Fluorescence Imaging Systems

    • Standalone Fluorescence Imaging Systems

    • Optical + X ray/ Optical + CT systems



  • Nuclear Imaging Systems

    • Micro-PET Systems

    • Micro-Spect Systems

    • Trimodality (Spect/PET/CT) Systems



  • Micro-MRI

  • Micro-Ultrasound

  • Micro-CT

  • Photoacoustic Imaging System

  • Magnetic Particle Imaging Systems


Global Preclinical Imaging Market, by Reagent



  • Preclinical Optical Imaging Reagents

    • Bioluminescent Imaging Reagents

    • Fluorescent Imaging Reagents



  • Preclinical Nuclear Imaging Reagents

    • Preclinical PET Tracers

    • Preclinical Spect Probes



  • Preclinical MRI Contrast Agents

  • Preclinical Ultrasound Contrast Agents

  • Preclinical CT Contrast Agents


Global Preclinical Imaging Market, by Region



  • Americas

    • North America

      • US

      • Canada



    • South America



  • Europe

    • Western Europe

      • Germany

      • France

      • Italy

      • Spain

      • UK



    • Rest of Western Europe

    • Eastern Europe



  • Asia-Pacific

    • Japan

    • China

    • India

    • Australia

    • South Korea

    • Rest of Asia-Pacific



  • The Middle East & Africa

    • Middle East

    • Africa




Global Preclinical Imaging Market, by Key Players



  • Bruker Corporation (US)

  • MR Solutions (UK)

  • PerkinElmer (US)

  • Fujifilm Holdings Corporation (Japan)

  • Milabs B.V. (The Netherlands)

  • Mediso Ltd. (Hungary)

  • Miltenyi Biotec GmbH (Germany)

  • LI-COR, Inc. (US)

  • Aspect Imaging (Israel)

  • Trifoil Imaging (US)


Intended Audience



  • Preclinical Imaging Manufacturers and vendors

  • Research organization and CRO

  • Various research and consulting firms



Frequently Asked Questions (FAQ) :


The Preclinical Imaging Market is projected to grow at a 6.3% CAGR between 2018-2023.

The Americas are expected to spearhead the Preclinical Imaging Market.

Key competitors in the Preclinical Imaging Market include Trifoil Imaging (US), Aspect Imaging (Israel), Miltenyi Biotec GmbH (Germany), LI-COR, Inc. (US), Mediso Ltd. (Hungary), Milabs B.V. (The Netherlands), Fujifilm Holdings Corporation (Japan), PerkinElmer Inc. (US), MR Solutions (UK), and Bruker Corporation (US).

It finds extensive applications in cardiac imaging, orthopaedics, anatomical and functional neuroimaging, cancer research, infectious diseases, inflammation, cardiology, and neurology.

Strategies adopted by industry players to maintain dominance in the Preclinical Imaging Market include product innovations and launches, partnerships, and mergers.

Table of Contents:

Chapter 1. Report Prologue

Chapter 2. Market Introduction

2.1. Definition

2.2. Scope of the Study

2.2.1. Research Objective

2.2.2. Assumptions

2.2.3. Limitations

Chapter 3. Research Methodology

3.1. Introduction

3.2. Primary Research

3.3. Secondary Research

3.4. Market Reagent Estimation

Chapter 4. Market Dynamics

4.1. Drivers

4.2. Restraints

4.3. Opportunities

4.4. Challenges

Chapter 5. Market Factor Analysis

5.1. Porter’s Five Forces Analysis

5.1.1. Bargaining Power of Suppliers

5.1.2. Bargaining Power of Buyers

5.1.3. Threat of New Entrants

5.1.4. Threat of Substitutes

5.1.5. Intensity of Rivalry

5.2. Value Chain Analysis

5.3. Investment Feasibility Analysis

5.4. Pricing Analysis

Chapter 6. Global Preclinical Imaging Market, by Modality

6.1. Introduction

6.2. Optical Imaging Systems

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

6.2.1. Bioluminescence/Fluorescence Imaging Systems

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

6.2.2. Standalone Fluorescence Imaging Systems

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

6.2.3. Optical + X ray/ Optical + CT systems

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

6.3. Nuclear Imaging Systems

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

6.3.1. Micro-PET Systems

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

6.3.2. Micro-Spect Systems

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

6.3.3. Trimodality (Spect/PET/CT) Systems

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

6.4. Micro-MRI

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

6.5. Micro-Ultrasound

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

6.6. Micro-CT

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

6.7. Photoacoustic Imaging System

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

6.8. Magnetic Particle Imaging Systems

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

Chapter 7. Global Preclinical Imaging Market, by Reagent

7.1. Introduction

7.2. Preclinical Optical Imaging Reagents

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

7.2.1. Bioluminescent Imaging Reagents

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

7.2.2. Fluorescent Imaging Reagents

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

7.3. Preclinical Nuclear Imaging Reagents

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

7.3.1. Preclinical PET Tracers

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

7.3.2. Preclinical Spect Probes

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

7.4. Preclinical MRI Contrast Agents

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

7.5. Preclinical Ultrasound Contrast Agents

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

7.6. Preclinical CT Contrast Agents

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

Chapter 8. Global Preclinical Imaging Market, by Region

8.1. Introduction

8.2. Americas

8.2.1. North America

8.2.1.1. US

8.2.1.2. Canada

8.2.2. Latin America

8.3. Europe

8.3.1. Western Europe

8.3.1.1. Germany

8.3.1.2. France

8.3.1.3. Italy

8.3.1.4. Spain

8.3.1.5. UK

8.3.1.6. Rest of Western Europe

8.3.2. Eastern Europe

8.4. Asia-Pacific

8.4.1. Japan

8.4.2. China

8.4.3. India

8.4.4. Australia

8.4.5. South Korea

8.4.6. Rest of Asia-Pacific

8.5. Middle East & Africa

8.5.1. Middle East

8.5.2. Africa

Chapter 9. Company Landscape

9.1. Introduction

9.2. Market Share Analysis

Chapter 10. Company Profiles

10.1. Bruker Corporation

10.1.1. Company Overview

10.1.2. Modality Overview

10.1.3. Financials Overview

10.1.4. Key Developments

10.1.5. SWOT Analysis

10.1.6. Key Strategies

10.2. MR Solutions

10.2.1. Company Overview

10.2.2. Modality Overview

10.2.3. Financials Overview

10.2.4. Key Developments

10.2.5. SWOT Analysis

10.2.6. Key Strategies

10.3. PerkinElmer Inc.

10.3.1. Company Overview

10.3.2. Modality Overview

10.3.3. Financials Overview

10.3.4. Key Developments

10.3.5. SWOT Analysis

10.3.6. Key Strategies

10.4. Fujifilm Holdings Corporation

10.4.1. Company Overview

10.4.2. Modality Overview

10.4.3. Financials Overview

10.4.4. Key Developments

10.4.5. SWOT Analysis

10.4.6. Key Strategies

10.5. Milabs B.V.

10.5.1. Company Overview

10.5.2. Modality Overview

10.5.3. Financials Overview

10.5.4. Key Developments

10.5.5. SWOT Analysis

10.5.6. Key Strategies

10.6. Mediso Ltd.

10.6.1. Company Overview

10.6.2. Modality Overview

10.6.3. Financials Overview

10.6.4. Key Developments

10.6.5. SWOT Analysis

10.6.6. Key Strategies

10.7. LI-COR, Inc.

10.7.1. Company Overview

10.7.2. Modality Overview

10.7.3. Financials Overview

10.7.4. Key Developments

10.7.5. SWOT Analysis

10.7.6. Key Strategies

10.8. Aspect Imaging

10.8.1. Company Overview

10.8.2. Modality Overview

10.8.3. Financials Overview

10.8.4. Key Developments

10.8.5. SWOT Analysis

10.8.6. Key Strategies

10.9. Trifoil Imaging

10.9.1. Company Overview

10.9.2. Modality Overview

10.9.3. Financials Overview

10.9.4. Key Developments

10.9.5. SWOT Analysis

10.9.6. Key Strategies

10.10. Miltenyi Biotec GmbH

10.10.1. Company Overview

10.10.2. Modality Overview

10.10.3. Financials Overview

10.10.4. Key Developments

10.10.5. SWOT Analysis

10.10.6. Key Strategies

10.11. Others

Chapter 11. MRFR Conclusion

11.1. Key Findings

11.1.1. From CEO’s View point

11.1.2. Unmet Needs of the Market

11.2. Key Companies to Watch

11.3. Predictions for the Preclinical Imaging Industry

Chapter 12. Appendix

LIST OF TABLES

Table 1. Global Preclinical Imaging Market Synopsis, 2020-2027

Table 2. Global Preclinical Imaging Market Estimates and Forecast, 2020-2027 (USD Million)

Table 3. Global Preclinical Imaging Market, by Region, 2020-2027 (USD Million)

Table 4. Global Preclinical Imaging Market, by Modality, 2020-2027 (USD Million)

Table 5. Global Preclinical Imaging Market, by Reagent, 2020-2027 (USD Million)

Table 6. North America: Preclinical Imaging Market, by Modality, 2020-2027 (USD Million)

Table 7. North America: Preclinical Imaging Market, by Reagent, 2020-2027 (USD Million)

Table 8. US: Preclinical Imaging Market, by Modality, 2020-2027 (USD Million)

Table 9. US: Preclinical Imaging Market, by Reagent, 2020-2027 (USD Million)

Table 10. Canada: Preclinical Imaging Market, by Modality, 2020-2027 (USD Million)

Table 11. Canada: Preclinical Imaging Market, by Reagent, 2020-2027 (USD Million)

Table 12. Latin America: Preclinical Imaging Market, by Modality, 2020-2027 (USD Million)

Table 13. Latin America: Preclinical Imaging Market, by Reagent, 2020-2027 (USD Million)

Table 14. Europe: Preclinical Imaging Market, by Modality, 2020-2027 (USD Million)

Table 15. Europe: Preclinical Imaging Market, by Reagent, 2020-2027 (USD Million)

Table 16. Western Europe: Preclinical Imaging Market, by Modality, 2020-2027 (USD Million)

Table 17. Western Europe: Preclinical Imaging Market, by Reagent, 2020-2027 (USD Million)

Table 18. Eastern Europe: Preclinical Imaging Market, by Modality, 2020-2027 (USD Million)

Table 19. Eastern Europe: Preclinical Imaging Market, by Reagent, 2020-2027 (USD Million)

Table 20. Asia-Pacific: Preclinical Imaging Market, by Modality, 2020-2027 (USD Million)

Table 21. Asia-Pacific: Preclinical Imaging Market, by Reagent, 2020-2027 (USD Million)

Table 22. Middle East & Africa: Preclinical Imaging Market, by Modality, 2020-2027 (USD Million)

Table 23. Middle East & Africa: Preclinical Imaging Market, by Reagent, 2020-2027 (USD Million)

LIST OF FIGURES

Figure 1. Research Process

Figure 2. Segmentation for Global Preclinical Imaging Market

Figure 3. Market Dynamics for Global Preclinical Imaging Market

Figure 4. Global Preclinical Imaging Market Share, by Modality, 2020

Figure 5. Global Preclinical Imaging Market Share, by Reagent, 2020

Figure 6. Global Preclinical Imaging Market Share, by Region, 2020

Figure 7. North America: Preclinical Imaging Market Share, by Country, 2020

Figure 8. Europe: Preclinical Imaging Market Share, by Country, 2020

Figure 9. Asia-Pacific: Preclinical Imaging Market Share, by Country, 2020

Figure 10. Middle East & Africa: Preclinical Imaging Market Share, by Country, 2020

Figure 11. Global Preclinical Imaging Market: Company Share Analysis, 2020 (%)

Figure 12. Bruker Corporation: Key Financials

Figure 13. Bruker Corporation: Segmental Revenue

Figure 14. Bruker Corporation: Geographical Revenue

Figure 15. MR Solutions: Key Financials

Figure 16. MR Solutions: Segmental Revenue

Figure 17. MR Solutions: Geographical Revenue

Figure 18. PerkinElmer Inc.: Key Financials

Figure 19. PerkinElmer Inc.: Segmental Revenue

Figure 20. PerkinElmer Inc.: Geographical Revenue

Figure 21. Fujifilm Holdings Corporation: Key Financials

Figure 22. Fujifilm Holdings Corporation: Segmental Revenue

Figure 23. Fujifilm Holdings Corporation: Geographical Revenue

Figure 24. Milabs B.V.: Key Financials

Figure 25. Milabs B.V.: Segmental Revenue

Figure 26. Milabs B.V.: Geographical Revenue

Figure 27. Mediso Ltd.: Key Financials

Figure 28. Mediso Ltd.: Segmental Revenue

Figure 29. Mediso Ltd.: Geographical Revenue

Figure 30. LI-COR, Inc.: Key Financials

Figure 31. LI-COR, Inc.: Segmental Revenue

Figure 32. LI-COR, Inc.: Geographical Revenue

Figure 33. Aspect Imaging: Key Financials

Figure 34. Aspect Imaging: Segmental Revenue

Figure 35. Aspect Imaging: Geographical Revenue

Figure 36. Trifoil Imaging: Key Financials

Figure 37. Trifoil Imaging: Segmental Revenue

Figure 38. Trifoil Imaging: Geographical Revenue

Figure 39. Miltenyi Biotec GmbH: Key Financials

Figure 40. Miltenyi Biotec GmbH: Segmental Revenue

Figure 41. Miltenyi Biotec GmbH: Geographical Revenue



This table of content is tentative and subject to change as the research progresses.

Please Note:  Financial details of company cannot be provided if the information of the company is not available in public domain and or reliable source.